Guardant Health, Inc. (GH) [Rocket]

Overview

Guardant Health, Inc. (GH)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
10/05/2023	4	Joyce Meghan V. (Director) has filed a Form 4 on Guardant Health, Inc.
10/02/2023	4	Saia John G. (Chief Legal Officer) has filed a Form 4 on Guardant Health, Inc.
10/02/2023	4	Merrill Amelia (SVP, People) has filed a Form 4 on Guardant Health, Inc.
10/02/2023	4	Kalia Kumud (Chief Information Officer) has filed a Form 4 on Guardant Health, Inc.
10/02/2023	4	Freeman Chris (Chief Commercial Officer) has filed a Form 4 on Guardant Health, Inc.
10/02/2023	4	EAGLE CRAIG (Chief Medical Officer) has filed a Form 4 on Guardant Health, Inc.
10/02/2023	4	Chudova Darya (Chief Technology Officer) has filed a Form 4 on Guardant Health, Inc.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16
Revenues	449.5	373.7	286.7	214.4	90.6	49.8	25.2
Revenue growth	20.3%	30.3%	33.8%	136.5%	81.9%	97.4%
Cost of goods sold	156.3	122.9	92.5	70.7	43.2	31.6	22.1
Gross profit	293.2	250.7	194.2	143.7	47.4	18.2	3.1
Gross margin	65.2%	67.1%	67.7%	67.0%	52.3%	36.6%	12.4%
Sales and marketing	299.8	191.9	106.5	78.3	53.5	32.5	26.2
Research and development	373.8	263.2	149.9	86.3	50.7	25.6	10.9
General and administrative	164.0	206.6	192.8	61.4	36.2	36.8	9.9
EBITA	-541.9	-409.1	-253.2	-81.7	-92.9	-76.6	-43.8
EBITA margin	-120.5%	-109.5%	-88.3%	-38.1%	-102.5%	-153.7%	-173.7%
Amortization of intangibles	2.5	1.9	1.8	0.7
EBIT	-544.4	-411.0	-255.0	-82.4	-92.9	-76.6	-43.8
EBIT margin	-121.1%	-110.0%	-88.9%	-38.4%	-102.5%	-153.7%	-173.7%
Pre-tax income	-653.4	-384.5	-245.9	-69.7	-84.2	-83.2	-46.1
Income taxes	1.1	0.3	0.4	-1.9	0.0	0.0	0.0
Tax rate				2.7%
Net income	-654.6	-405.7	-253.8	-75.7	-85.1	-89.0	-46.1
Net margin	-145.6%	-108.6%	-88.5%	-35.3%	-93.8%	-178.6%	-182.7%

Diluted EPS	($6.41)	($4.00)	($2.60)	($0.84)	($2.80)	($7.07)	($3.53)
Shares outstanding (diluted)	102.2	101.3	97.5	90.6	30.4	12.6	13.1

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.